215 related articles for article (PubMed ID: 1849626)
1. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
Kurman RJ; Malkasian GD; Sedlis A; Solomon D
Obstet Gynecol; 1991 May; 77(5):779-82. PubMed ID: 1849626
[TBL] [Abstract][Full Text] [Related]
2. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System.
Syrjänen K; Kataja V; Yliskoski M; Chang F; Syrjänen S; Saarikoski S
Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):675-82. PubMed ID: 1314359
[TBL] [Abstract][Full Text] [Related]
3. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
[TBL] [Abstract][Full Text] [Related]
4. Polymerase chain reaction-assisted evaluation of low and high grade squamous intraepithelial lesion cytology and reappraisal of the Bethesda System.
Kühler-Obbarius C; Milde-Langosch K; Löning T; Stegner HE
Acta Cytol; 1994; 38(5):681-6. PubMed ID: 8091897
[TBL] [Abstract][Full Text] [Related]
5. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
[TBL] [Abstract][Full Text] [Related]
6. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
7. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
[TBL] [Abstract][Full Text] [Related]
8. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
9. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
Sherman ME; Kelly D
Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion.
Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF
J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557
[TBL] [Abstract][Full Text] [Related]
11. [Detection of various papilloma virus types in cytologic smears of precancerous conditions and cancers of the uterine cervix].
Wagner D; de Villiers EM; Gissmann L
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):226-31. PubMed ID: 2989076
[TBL] [Abstract][Full Text] [Related]
12. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix.
Negrini BP; Schiffman MH; Kurman RJ; Barnes W; Lannom L; Malley K; Brinton LA; Delgado G; Jones S; Tchabo JG
Cancer Res; 1990 Aug; 50(15):4670-5. PubMed ID: 2164444
[TBL] [Abstract][Full Text] [Related]
14. The Bethesda classification for squamous intraepithelial lesions: histologic, cytologic, and viral correlates.
Tabbara S; Saleh AD; Andersen WA; Barber SR; Taylor PT; Crum CP
Obstet Gynecol; 1992 Mar; 79(3):338-46. PubMed ID: 1738511
[TBL] [Abstract][Full Text] [Related]
15. [The Papanicolaou classification in the Bethesda system (National Cancer Institute, Bethesda, Maryland)].
Broso PR; Buffetti G
Minerva Ginecol; 1993 Nov; 45(11):557-63. PubMed ID: 8121604
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the atypical cytologic smear. Validity of the 1991 Bethesda System.
Widra EA; Dookhan D; Jordan A; McCue P; Bibbo M; Dunton CJ
J Reprod Med; 1994 Sep; 39(9):682-4. PubMed ID: 7807479
[TBL] [Abstract][Full Text] [Related]
17. The terminology of pre-invasive cervical lesions in the UK cervical screening programme.
Herrington CS
Cytopathology; 2015 Dec; 26(6):346-50. PubMed ID: 26767601
[TBL] [Abstract][Full Text] [Related]
18. Is it possible to define a better ASCUS class in cervicovaginal screening? A review of 187 cases.
Guerrini L; Sama D; Visani M; Cotignoli T; Sintoni C; Maioli P; Lanzanova G; Schincaglia P
Acta Cytol; 2001; 45(4):532-6. PubMed ID: 11480714
[TBL] [Abstract][Full Text] [Related]
19. Is the HSIL subclassification cytologically real and clinically justified?
Milicić-Juhas V; Pajtler M
Coll Antropol; 2010 Jun; 34(2):395-400. PubMed ID: 20698108
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and survey of abnormal/atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: a retrospective study.
Giudice A; Rizzo M; Rossi RT; Bonaffini O; Buda CA; Pettineo G
Anticancer Res; 2000; 20(2B):1195-9. PubMed ID: 10810421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
